S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:BSTG

Biostage (BSTG) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free BSTG Stock Alerts
$4.45
0.00 (0.00%)
(As of 07/24/2023)
Compare
Today's Range
$4.45
▼
$4.45
50-Day Range
$4.45
▼
$4.45
52-Week Range
$4.45
▼
$4.45
Volume
N/A
Average Volume
1,847 shs
Market Capitalization
$61.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisEarnings
BSTG stock logo

About Biostage Stock (OTCMKTS:BSTG)

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

BSTG Stock Price History

BSTG Stock News Headlines

January 5, 2024 | investing.com
Harvard Apparatus Regenerative Technology Inc (HRGN)
August 22, 2023 | seekingalpha.com
HRGN Harvard Apparatus Regenerative Technology Inc.
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
July 20, 2023 | finance.yahoo.com
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)
July 18, 2023 | finance.yahoo.com
Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease
July 11, 2023 | benzinga.com
Biostage CEO Awarded $1.07M Worth of Stock Options
June 13, 2023 | finance.yahoo.com
Biostage to Host Investor Call
May 31, 2023 | finance.yahoo.com
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
May 16, 2023 | benzinga.com
Biostage Stock (OTC:BSTG), Insider Trading Activity
April 24, 2023 | sg.finance.yahoo.com
Biostage, Inc. (BSTG) stock historical prices & data – Yahoo Finance
April 23, 2023 | ca.finance.yahoo.com
Biostage, Inc. (BSTG) Stock Historical Prices & Data - Yahoo Finance
April 10, 2023 | finance.yahoo.com
Biostage Appoints Ron Packard to Board of Directors
April 6, 2023 | finance.yahoo.com
Biostage Announces $6 Million Financing to Advance Clinical Trial
March 2, 2023 | finance.yahoo.com
Biostage Announces Chairman and CEO Transition
February 3, 2023 | msn.com
Regenerative medicine developer Biostage cancels Nasdaq uplisting, public offering
January 12, 2023 | finance.yahoo.com
Biostage Amends CEO Employment Agreement
December 28, 2022 | finance.yahoo.com
Biostage, Inc. (OTC:BSTG) Q3 2022 Earnings Call Transcript
December 28, 2022 | prnewswire.com
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer
December 23, 2022 | finance.yahoo.com
New Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal Implant
November 15, 2022 | seekingalpha.com
Biostage, Inc. (BSTG) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Biostage Reports Corporate Highlights and Third Quarter Financial Results
November 10, 2022 | finance.yahoo.com
Biostage Schedules Conference Call and Webcast for Q3 2022 Results
October 29, 2022 | seekingalpha.com
Regenerative therapy developer Biostage files for Nasdaq uplisting, $6M offering
October 25, 2022 | finance.yahoo.com
Biostage Receives U.S. Patent for Cellularized Patch-Based Scaffolds for Organ Repair
August 8, 2022 | finance.yahoo.com
Biostage Announces Appointment of New Chief Financial Officer
August 4, 2022 | finance.yahoo.com
Biostage Reports Corporate Highlights and Second Quarter Financial Results
See More Headlines
Receive BSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostage and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2020
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:BSTG
CUSIP
N/A
CIK
1563665
Web
www.biostage.com
Phone
(744) 233-7300
Fax
774-233-7302
Employees
7
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,070,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-174.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.73
Quick Ratio
2.73

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.26) per share
Price / Book
-17.12

Miscellaneous

Outstanding Shares
13,882,000
Free Float
11,758,000
Market Cap
$61.77 million
Optionable
Not Optionable
Beta
-1.02
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Junli He (Age 49)
    CEO & Chairman
  • Mr. Yu Hong (Age 50)
    Pres
    Comp: $158.06k
  • Dr. William L. Fodor Ph.D. (Age 64)
    Chief Scientific Officer
    Comp: $207.85k
  • Mr. Joseph L. Damasio Jr. (Age 49)
    Chief Financial Officer
  • Dr. Shunfu Hu Ph.D.
    VP of Bus. Devel. & Operations

Key Competitors

View All Competitors

BSTG Stock Analysis - Frequently Asked Questions

How have BSTG shares performed in 2024?

Biostage's stock was trading at $4.45 at the beginning of the year. Since then, BSTG stock has increased by 0.0% and is now trading at $4.45.
View the best growth stocks for 2024 here.

How were Biostage's earnings last quarter?

Biostage, Inc. (OTCMKTS:BSTG) issued its earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter.

What other stocks do shareholders of Biostage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biostage investors own include Fulcrum Therapeutics (FULC), Allena Pharmaceuticals (ALNA), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Arbutus Biopharma (ABUS), Akero Therapeutics (AKRO), Ampliphi Biosciences (APHB), Ardelyx (ARDX), Armata Pharmaceuticals (ARMP) and Athersys (ATHX).

How do I buy shares of Biostage?

Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BSTG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press